/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.06%
Natural Gas
-3.02%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+1.02%
VIX
N/A
Economic Calendar
EUR/USD
-0.06%
Natural Gas
-3.02%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
+1.02%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Bitcoin Runes (BRC-20) Pull $135m in Fees Post-Halving
about 6 hours ago
Michigan Consumer Confidence Drops To 77.2 In April, Missing Analyst Expectations
about 12 hours ago
Fed Inflation Gauge Surges to 2.8% in March, Surpassing Expectations
about 12 hours ago
Bank of Japan Monetary Policy Decision Sends the USD/JPY to 156
about 23 hours ago
Tech Giants Excel: Alphabet’s Dividend, Microsoft’s AI Growth, Snap’s Q1 Surge
1 day ago
Microsoft and Alphabet Bracing for Key Earnings Release
1 day ago
Gold Price Forecast: Faces Resistance, Risk of Deeper Pullback Looms
about 6 hours ago
Natural Gas Price Forecast: Upside Breakout from Consolidation, Eyes Higher Levels
about 6 hours ago
S&P 500: More Uncertainty Following Earnings, Weak GDP Number
about 6 hours ago
Dogecoin (DOGE) Price at Risk: Can the $0.15 Support Hold?
about 6 hours ago
Big Money Instrumental in Bruker Stock Rise
about 6 hours ago
Allison Transmission Shares Driven by Big Money
about 6 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
BIO
profile
Bio-Rad Laboratories Inc. - Class A
Follow
BIO
(
NYSE
)
N/A
275.92
+0.32 (+0.12%)
in
:
usd
•
As of: Apr 26, 2024 15:59
UTC -4
Open
275.00
High
279.32
Low
273.84
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
About
Bio-Rad Laboratories Inc. - Class A
CEO
Norman Schwartz
Headquarters
1000 alfred nobel drive
hercules, ca 94547, united states
Auditor
KPMG LLP
Employees
8,030
Share Holders
232
Website
www.bio rad.com
Industry
medical specialties
Sector
health technology
Company Overview
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
Bio-Rad Laboratories Inc. - Class A
Statistics
Valuation Measures
Market Capitalization
2
7.93B
Enterprise Value
8.73B
Enterprise Value/EBITDA
(ttm)
25.84
Price to Earnings Ratio
(ttm)
23.64
Price to Book
(mrq)
0.91
Price to Sales
(ttm)
2.97
Price to Cash
(ytd)
22.98
Profitability
Gross Margin
(ttm)
53.41%
Operating Margin
(ttm)
12.92%
Profit Margin
(ttm)
-23.08%
Return on Equity
(ttm)
3.90%
Return on Invested Capital
(ttm)
-6.80%
Return on Assets
(ttm)
2.77%
Income Statement
Revenue
(ttm)
2.67B
Revenue Per Share
(ttm)
93.67
Gross Profit
(ttm)
1.43B
EBITDA
(ttm)
3
337.80M
Net Income Avi to Common
(ttm)
-637.32M
Diluted EPS
(ttm)
-21.49
Share Statistics
Beta (5Y Monthly)
0.87
52-Week Change
-36.72%
S&P500 52-Week Change
25.74%
S&P500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding
1
28.52M
Dividend Yield
0.00%
Float
4
23.65M
%
Held by Insiders
17.06%
%
Held by Institutions
65.24%
Balance Sheet
Total Cash
(mrq)
1.61B
Total Cash Per Share
(mrq)
56.55
Total Debt
(mrq)
1.20B
Total Debt/Equity
(mrq)
13.72%
Current Ratio
(mrq)
5.83%
Quick Ratio
(mrq)
4.34%
Book Value Per Share
(mrq)
306.50
Cash Flow
Operating Cash Flow Per Share
(ytd)
12.84
Free Cash Flow
(ytd)
218.47M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker